Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Frontline lenalidomide for cardiac AL amyloidosis
KCT0003604Phase 2Completed
- Sponsor
- Seoul National University Hospital
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of lenalidomide in light-chain amyloidosis, sponsored by Seoul National University Hospital. Started Nov 2019; status: completed.
02
Drugs
lenalidomide
03
Conditions
light-chain amyloidosis
Beyond the preview
Go deeper on KCT0003604.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0003604.